Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ucla Center for Clinical Aids Research and Education (care)
Los Angeles, California, United States
Judith Currier, MDPriscilla Hsue, MD →Recruiting - San Francisco General Hospital
San Francisco, California, United States
Adam Spivak, MDAhmed Tawakol, MDBorek Foldyna, MDJohn Kornak, MDMichael Lu, MDMiguel Pampaloni, MDPriscilla Hsue, MD →Steven Deeks, MDYoojin Lee, MDRecruiting - Ut Health Houston
Houston, Texas, United States
Jordan Lake, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Mar 2023
- Primary completion
- 1 Mar 2028
- Completion
- 1 Mar 2028
- Last update posted
- 17 Dec 2025
- Registered enrollment
- 121
- Registry id
- NCT05488431
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.